Investigational Site Number :8400002

Los Angeles, California 90027

0 studies enrolling now · 3 studies all time

What they study most

Alport Syndrome, Chronic Obstructive Pulmonary Disease, Dermatitis Atopic

Studies at this site

• Dupilumab-PEdiatric Skin Barrier Function and LIpidomics STudy in Patients With Atopic Dermatitis — Completed
• Study of Lademirsen (SAR339375) in Patients With Alport Syndrome — Stopped early
• Proof-of-Concept Study to Assess the Efficacy, Safety and Tolerability of SAR440340 (Anti-IL-33 mAb) in Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD) — Completed